446 related articles for article (PubMed ID: 12501128)
1. Effect of highly active antiretroviral therapy (HAART) and hepatitis C Co-infection on hyperlipidemia in HIV-infected patients: a retrospective longitudinal study.
Patroni A; Torti C; Tomasoni L; Quiros Roldan E; Bertelli D; Puoti M; Cadeo GP; Sleiman I; Tinelli C; Carosi G; Castelli F
HIV Clin Trials; 2002; 3(6):451-61. PubMed ID: 12501128
[TBL] [Abstract][Full Text] [Related]
2. Metabolic changes associated with antiretroviral therapy in HIV-positive patients.
Almeida SE; Borges M; Fiegenbaum M; Nunes CC; Rossetti ML
Rev Saude Publica; 2009 Apr; 43(2):283-90. PubMed ID: 19225696
[TBL] [Abstract][Full Text] [Related]
3. The prevalence and risk of hepatitis flares in a Serbian cohort of HIV and HCV co-infected patients treated with HAART.
Jevtović Dj; Ranin J; Salemović D; Pesić I; Dragović G; Zerjav S; Djurković-Djaković O
Biomed Pharmacother; 2008 Jan; 62(1):21-5. PubMed ID: 17223307
[TBL] [Abstract][Full Text] [Related]
4. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
5. Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviral therapy.
Duong M; Petit JM; Piroth L; Grappin M; Buisson M; Chavanet P; Hillon P; Portier H
J Acquir Immune Defic Syndr; 2001 Jul; 27(3):245-50. PubMed ID: 11464143
[TBL] [Abstract][Full Text] [Related]
6. Lipodystrophy and metabolic abnormalities in Slovenian HIV-infected patients.
Tomazic J; Silic A; Karner P; Vidmar L; Maticic M; Poljak M; Ihan A; Janez A
Wien Klin Wochenschr; 2004 Nov; 116(21-22):755-9. PubMed ID: 15628647
[TBL] [Abstract][Full Text] [Related]
7. Mitigation of antiretroviral-induced hyperlipidemia by hepatitis C virus co-infection.
Cooper CL; Mills E; Angel JB
AIDS; 2007 Jan; 21(1):71-6. PubMed ID: 17148970
[TBL] [Abstract][Full Text] [Related]
8. Effects of highly active antiretroviral therapy (HAART) on cholesterol in HIV-1 infected children: a retrospective cohort study.
Kim JY; Zaoutis T; Chu J; Zhao H; Rutstein R
Pharmacoepidemiol Drug Saf; 2009 Jul; 18(7):589-94. PubMed ID: 19402031
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C infection on immune recovery in HIV-positive patients on successful HAART: the role of genotype 3.
Seminari E; Tinelli C; Ravasi G; Ripamonti D; Ladisa N; Marino N; Sighinolfi L; Mondello P; Migliorino M; Carosi G; Maserati R;
Curr HIV Res; 2010 Apr; 8(3):186-93. PubMed ID: 20163342
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
Feleke Y; Fekade D; Mezegebu Y
Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
[TBL] [Abstract][Full Text] [Related]
11. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.
Jones R; Sawleshwarkar S; Michailidis C; Jackson A; Mandalia S; Stebbing J; Bower M; Nelson M; Gazzard BG; Moyle GJ
HIV Med; 2005 Nov; 6(6):396-402. PubMed ID: 16268821
[TBL] [Abstract][Full Text] [Related]
12. Dyslipidemia in a cohort of HIV-infected Latin American children receiving highly active antiretroviral therapy.
Brewinski M; Megazzini K; Hance LF; Cruz MC; Pavia-Ruz N; Della Negra M; Ferreira FG; Marques H; Hazra R;
J Trop Pediatr; 2011 Oct; 57(5):324-32. PubMed ID: 20889625
[TBL] [Abstract][Full Text] [Related]
13. A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study.
Carr A; Chuah J; Hudson J; French M; Hoy J; Law M; Sayer D; Emery S; Cooper DA
AIDS; 2000 Jun; 14(9):1171-80. PubMed ID: 10894281
[TBL] [Abstract][Full Text] [Related]
14. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
15. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
[TBL] [Abstract][Full Text] [Related]
16. Highly active antiretroviral therapy-related hepatotoxicity in human immunodeficiency virus and hepatitis C virus co-infected patients with advanced liver fibrosis in Taiwan.
Chou CC; Tsai HC; Wu KS; Sy CL; Chen JK; Chen YS; Lee SS
J Microbiol Immunol Infect; 2016 Aug; 49(4):546-53. PubMed ID: 25440980
[TBL] [Abstract][Full Text] [Related]
17. Impact of chronic hepatitis C infection on outcomes of patients with an advanced stage of HIV-1 infection in an area of low prevalence of co-infection.
Hung CC; Chen MY; Hsieh SM; Hsiao CF; Sheng WH; Chang SC
Int J STD AIDS; 2005 Jan; 16(1):42-8. PubMed ID: 15705272
[TBL] [Abstract][Full Text] [Related]
18. Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort.
Estrada V; Geijo P; Fuentes-Ferrer M; Alcalde ML; Rodrigo M; Galindo MJ; Muñoz A; Domingo P; Ribera E; Cosín J; Viciana P; Lozano F; Terrón A; Vergara A; Teira R; Muñoz-Sánchez J; Roca B; Sánchez T; López-Aldeguer J; Deig E; Vidal F; Pedrol E; Castaño-Carracedo M; Puig T; Garrido M; Suárez-Lozano I
BMC Womens Health; 2011 Aug; 11():36. PubMed ID: 21816091
[TBL] [Abstract][Full Text] [Related]
19. Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
Aurpibul L; Puthanakit T; Lee B; Mangklabruks A; Sirisanthana T; Sirisanthana V
Antivir Ther; 2007; 12(8):1247-54. PubMed ID: 18240864
[TBL] [Abstract][Full Text] [Related]
20. Serum lipids and glucose abnormalities in HIV/AIDS patients on antiretroviral therapies.
Salami AK; Akande AA; Olokoba AB
West Afr J Med; 2009 Jan; 28(1):10-5. PubMed ID: 19662738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
